Moreover, the tumors treated with cisplatin or bearing deficiency of CK1ε and SRSF10 had decreased protein level of Bcl-xL and reduced tumor cell density (Fig. S6, E and G). The gene discussed is BCL2L1; the disease is neoplasm.